News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

CELLforCURE launches a process to find a buyer for its Les Ulis site

CELLforCURE, a subsidiary of the SEQENS Group, has informed its employee representatives of its decision to look for a potential buyer for its site in Les Ulis (Essonne). CELLforCURE specializes in the development and the contract manufacturing of Cell & Gene therapies.

Essential molecules’ production in France: our investment plan

Seqens’ commitment to reducing its carbon footprint

Nitrosamines: quick mobilization of a multidisciplinary team in response to regulatory changes

Our products contribute to the 17 United Nations SDGs

Improving customer service: a challenge for SEQENS group

Products & Technologies

The digitalisation of the maintenance function to better serve our customers

The Regulatory Affairs Team at Seqens: its strategic status for the Group and its customers

Analysis of hand sanitizers: SEQENS Bourgoin-Jallieu’s Quality Control Laboratory relies on Infra-Red technology

Press kit : Safety is at the heart of our activities

New collaboration between SEQENS and RONDOL

Products & Technologies

Flow Chemistry: an innovation to secure the Electronics supply-chain

Faced with the pandemic, the mobilization of the Seqens group’s quality and regulatory teams is essential

1 … 3 4 5 6 7

Contact